Genetic Basis of Congenital Heart Defects: Genes, Environment, and Counseling
Epidemiology
CHDs affect ~1% of live births (40,000/year in US). Most are multifactorial: genetic susceptibility + environmental triggers.
Key Genetic Pathways
| Process | Example Genes | Associated Defects |
| Cardiogenesis (heart tube formation, looping) | NKX2-5, TBX5, GATA4, HAND1/2 | ASD, VSD, conduction defects |
| Neural crest migration (outflow tract) | TFAP2B, SEMA3C, PLXNA2 | TOF, TGA, PTA, IAA |
| Left-right patterning | NODAL, LEFTY2, ZIC3 | Heterotaxy, AVSD |
| Chromatin remodeling | CHD7, KMT2D, KDM6A | CHARGE, Kabuki syndromes |
Environmental Risk Factors
- Maternal diabetes (pregestational > gestational) → 3–5× risk
- Rubella, CMV, toxoplasmosis (1st trimester)
- Alcohol (no safe threshold), teratogenic drugs (isotretinoin, valproate, thalidomide)
- Folate deficiency (periconceptional supplementation reduces risk)
- Obesity, advanced maternal age, assisted reproductive technology
Genetic Counseling
- Recurrence risk: 2–5% for isolated CHD (vs. 1% general); higher if syndromic
- Testing: chromosomal microarray, targeted panels, exome sequencing
- Prenatal: fetal echo at 18–22 weeks if risk factors
Treatment Outlook
Advances in surgical/interventional techniques allow >90% survival to adulthood for most defects. Lifelong cardiology follow-up needed.
Genetic Disorders - Related Articles